Harbor Capital Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.11M Buy
261,644
+88,129
+51% +$902K 0.25% 97
2025
Q4
$1.73M Buy
173,515
+11,398
+7% +$109K 0.13% 206
2025
Q3
$1.45M Sell
162,117
-435,043
-73% -$4.03M 0.11% 247
2025
Q2
$5.63M Buy
597,160
+10,717
+2% +$94.6K 0.24% 140
2025
Q1
$6.36M Buy
586,443
+111,721
+24% +$1.12M 0.29% 119
2024
Q4
$4.52M Buy
474,722
+24,882
+6% +$252K 0.2% 156
2024
Q3
$5.05M Buy
449,840
+264,610
+143% +$2.81M 0.22% 143
2024
Q2
$1.85M Buy
185,230
+137,727
+290% +$1.4M 0.14% 219
2024
Q1
$547K Buy
47,503
+3,683
+8% +$31.3K 0.07% 369
2023
Q4
$319K Buy
43,820
+3,606
+9% +$28.4K 0.06% 309
2023
Q3
$366K Sell
40,214
-18,076
-31% -$217K 0.08% 273
2023
Q2
$709K Buy
+58,290
New +$650K 0.14% 188

Other funds holding AHCO

Harbor Capital Advisors's AHCO Position: Q1 2026 in Review

Harbor Capital Advisors increased its AdaptHealth (AHCO) stake by 51% in Q1 2026, buying an estimated $902K and bringing the position to 261,644 shares worth $3.11M. The position accounts for 0.25% of the portfolio, ranked #97.

Harbor Capital Advisors first reported a position in AHCO in Q2 2023 and has held it in 12 quarters since. The position peaked at $6.36M in Q1 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Harbor Capital Advisors held 261,644 shares of AdaptHealth worth $3.11M as of Q1 2026.
  • Harbor Capital Advisors bought 88,129 AdaptHealth shares in Q1 2026, an estimated $902K.
  • AdaptHealth made up 0.25% of Harbor Capital Advisors's portfolio in Q1 2026, its #97 holding.
  • Harbor Capital Advisors first reported a position in AdaptHealth in Q2 2023 and has held it in 12 quarters since.
  • Harbor Capital Advisors's AdaptHealth position peaked at $6.36M in Q1 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.